Daniel Kazado, Director at IMMUNE PHARMACEUTICALS INC (IMNP), bought 150,000 shares at $0.78 ($117K) on 2015-12-07, disclosed to the SEC on 2015-12-08.
Open-market purchase of $117k IMNP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| IMNP | BUY | 2016-08-04 | $600K | — | Filing → |
| IMNP | BUY | 2015-09-16 | $74K | — | Filing → |
| IMNP | BUY | 2014-12-03 | $20K | — | Filing → |